Schachter H - Search Results

1

N-glycans are involved in the response of Caenorhabditis elegans to bacterial pathogens.

Shi H, Tan J, Schachter H. Shi H, et al. Among authors: schachter h. Methods Enzymol. 2006;417:359-89. doi: 10.1016/S0076-6879(06)17022-6. Methods Enzymol. 2006. PMID: 17132514

2

UDP-N-acetylglucosamine:alpha-3-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I and UDP-N-acetylglucosamine:alpha-6-D-mannoside beta-1,2-N-acetylglucosaminyltransferase II in Caenorhabditis elegans.

Chen S, Tan J, Reinhold VN, Spence AM, Schachter H. Chen S, et al. Among authors: schachter h. Biochim Biophys Acta. 2002 Dec 19;1573(3):271-9. doi: 10.1016/s0304-4165(02)00393-8. Biochim Biophys Acta. 2002. PMID: 12417409 Review.

3

The human UDP-N-acetylglucosamine: alpha-6-D-mannoside-beta-1,2- N-acetylglucosaminyltransferase II gene (MGAT2). Cloning of genomic DNA, localization to chromosome 14q21, expression in insect cells and purification of the recombinant protein.

Tan J, D'Agostaro AF, Bendiak B, Reck F, Sarkar M, Squire JA, Leong P, Schachter H. Tan J, et al. Among authors: schachter h. Eur J Biochem. 1995 Jul 15;231(2):317-28. doi: 10.1111/j.1432-1033.1995.tb20703.x. Eur J Biochem. 1995. PMID: 7635144 Free article.

4

Synthesis of pentasaccharide analogues of the N-glycan substrates of N-acetylglucosaminyltransferases III, IV and V using tetrasaccharide precursors and recombinant beta-(1-->2)-N-acetylglucosaminyltransferase II.

Reck F, Meinjohanns E, Tan J, Grey AA, Paulsen H, Schachter H. Reck F, et al. Among authors: schachter h. Carbohydr Res. 1995 Oct 2;275(2):221-9. doi: 10.1016/0008-6215(95)00091-7. Carbohydr Res. 1995. PMID: 8529222

5

Mutations in the MGAT2 gene controlling complex N-glycan synthesis cause carbohydrate-deficient glycoprotein syndrome type II, an autosomal recessive disease with defective brain development.

Tan J, Dunn J, Jaeken J, Schachter H. Tan J, et al. Among authors: schachter h. Am J Hum Genet. 1996 Oct;59(4):810-7. Am J Hum Genet. 1996. PMID: 8808595 Free PMC article.

6

Structure and function of the genes encoding N-acetylglucosaminyltransferases which initiate N-glycan antennae.

Schachter H, Chen SH, Zhou S, Tan J, Yip B, Sarkar M, Spence A. Schachter H, et al. Biochem Soc Trans. 1997 Aug;25(3):875-80. doi: 10.1042/bst0250875. Biochem Soc Trans. 1997. PMID: 9388565 Review. No abstract available.

7

Transcriptional regulation of the human UDP-GlcNAc:alpha-6-D-mannoside beta-1-2-N-acetylglucosaminyltransferase II gene (MGAT2) which controls complex N-glycan synthesis.

Chen SH, Zhou S, Tan J, Schachter H. Chen SH, et al. Among authors: schachter h. Glycoconj J. 1998 Mar;15(3):301-8. doi: 10.1023/a:1006957331273. Glycoconj J. 1998. PMID: 9579808

8

Inhibition of the sodium/potassium ATPase impairs N-glycan expression and function.

Beheshti Zavareh R, Lau KS, Hurren R, Datti A, Ashline DJ, Gronda M, Cheung P, Simpson CD, Liu W, Wasylishen AR, Boutros PC, Shi H, Vengopal A, Jurisica I, Penn LZ, Reinhold VN, Ezzat S, Wrana J, Rose DR, Schachter H, Dennis JW, Schimmer AD. Beheshti Zavareh R, et al. Among authors: schachter h. Cancer Res. 2008 Aug 15;68(16):6688-97. doi: 10.1158/0008-5472.CAN-07-6833. Cancer Res. 2008. PMID: 18701493

9

Defective glycosyltransferases are not good for your health.

Schachter H, Tan J, Sarkar M, Yip B, Chen S, Dunn J, Jaeken J. Schachter H, et al. Adv Exp Med Biol. 1998;435:9-27. doi: 10.1007/978-1-4615-5383-0_2. Adv Exp Med Biol. 1998. PMID: 9498061 Review. No abstract available.

10

Carbohydrate-deficient glycoprotein syndrome type II. An autosomal recessive N-acetylglucosaminyltransferase II deficiency different from typical hereditary erythroblastic multinuclearity, with a positive acidified-serum lysis test (HEMPAS).

Charuk JH, Tan J, Bernardini M, Haddad S, Reithmeier RA, Jaeken J, Schachter H. Charuk JH, et al. Among authors: schachter h. Eur J Biochem. 1995 Jun 1;230(2):797-805. doi: 10.1111/j.1432-1033.1995.0797h.x. Eur J Biochem. 1995. PMID: 7607254 Free article.

Fibroblast extracts from two patients with a recently described variant of this disease (CDGS type II) have previously been shown to have over 98% reduced activity of UDP-GlcNAc:alpha-6-D-mannoside beta-1,2-N-acetylglucosaminyltransferase II [GlcNAc-TII; Jaeken, J., Schachter …

Fibroblast extracts from two patients with a recently described variant of this disease (CDGS type II) have previously been shown to have ov …

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

226 results

Search Page

Filters